Bi Asset Management Fondsmaeglerselskab A Abbott Laboratories Transaction History

Bi Asset Management Fondsmaeglerselskab A

$9.48 Billion
Q4 2024

A detailed history of Bi Asset Management Fondsmaeglerselskab A transactions in Abbott Laboratories stock. As of the latest transaction made, Bi Asset Management Fondsmaeglerselskab A holds 320,823 shares of ABT stock, worth $42.3 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares

320,823

Holding current value

$42.3 Million

% of portfolio

0.38%

43 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$111.93 - $119.39 $35.9 Million - $38.3 Million	320,823 New	320,823 $36.3 Million
Q2 2024 Aug 14, 2024	BUY	$100.73 - $112.44 $1.44 Million - $1.6 Million	14,254 Added 6.0%	252,006 $26.2 Million
Q1 2024 May 03, 2024	BUY	$109.52 - $120.96 $1.87 Million - $2.07 Million	17,076 Added 7.74%	237,752 $27 Million
Q4 2023 Feb 09, 2024	SELL	$90.19 - $110.4 $6.25 Million - $7.65 Million	-69,335 Reduced 23.91%	220,676 $24.3 Million
Q3 2023 Nov 13, 2023	BUY	$95.53 - $114.62 $1.68 Million - $2.02 Million	17,624 Added 6.47%	290,011 $28.1 Million
Q2 2023 Aug 03, 2023	BUY	$100.78 - $112.29 $1.34 Million - $1.49 Million	13,299 Added 5.13%	272,387 $29.7 Million
Q1 2023 May 12, 2023	SELL	$96.86 - $114.01 $14.5 Million - $17.1 Million	-149,705 Reduced 36.62%	259,088 $26.2 Million
Q4 2022 Feb 13, 2023	BUY	$95.06 - $111.52 $7.77 Million - $9.11 Million	81,710 Added 24.98%	408,793 $44.9 Million
Q3 2022 Nov 07, 2022	BUY	$96.76 - $112.03 $824,975 - $955,167	8,526 Added 2.68%	327,083 $31.6 Million
Q2 2022 Aug 12, 2022	BUY	$102.07 - $123.37 $8.31 Million - $10 Million	81,379 Added 34.31%	318,557 $34.6 Million
Q1 2022 May 11, 2022	BUY	$114.02 - $139.04 $5.14 Million - $6.27 Million	45,104 Added 23.48%	237,178 $28.1 Million
Q4 2021 Feb 02, 2022	BUY	$115.53 - $141.46 $2.27 Million - $2.79 Million	19,691 Added 11.42%	192,074 $27 Million
Q3 2021 Nov 09, 2021	SELL	$116.66 - $129.06 $711,626 - $787,266	-6,100 Reduced 3.42%	172,383 $20.4 Million
Q2 2021 Aug 06, 2021	BUY	$105.79 - $124.53 $2.4 Million - $2.83 Million	22,701 Added 14.57%	178,483 $20.7 Million
Q1 2021 May 10, 2021	SELL	$108.84 - $128.23 $7.8 Million - $9.18 Million	-71,621 Reduced 31.5%	155,782 $18.7 Million
Q4 2020 Feb 12, 2021	SELL	$105.0 - $114.42 $3.34 Million - $3.64 Million	-31,848 Reduced 12.28%	227,403 $24.9 Million
Q3 2020 Nov 09, 2020	SELL	$91.64 - $111.29 $538,934 - $654,496	-5,881 Reduced 2.22%	259,251 $28.2 Million
Q2 2020 Aug 05, 2020	SELL	$76.57 - $98.0 $3.96 Million - $5.07 Million	-51,771 Reduced 16.34%	265,132 $24.2 Million
Q1 2020 May 11, 2020	BUY	$62.82 - $91.86 $1.58 Million - $2.31 Million	25,200 Added 8.64%	316,903 $25 Million
Q4 2019 Mar 19, 2020	BUY	$78.51 - $87.4 $635,695 - $707,677	8,097 Added 2.86%	291,703 $25.3 Million
Q3 2019 Mar 19, 2020	SELL	$81.84 - $88.74 $709,880 - $769,730	-8,674 Reduced 2.97%	283,606 $23.7 Million
Q2 2019 Mar 19, 2020	BUY	$72.88 - $85.0 $599,438 - $699,125	8,225 Added 2.9%	292,280 $24.6 Million
Q1 2019 Mar 19, 2020	BUY	$66.22 - $80.06 $4.18 Million - $5.05 Million	63,055 Added 28.53%	284,055 $22.7 Million
Q4 2018 Mar 19, 2020	SELL	$65.56 - $74.27 $111,452 - $126,259	-1,700 Reduced 0.76%	221,000 $16 Million
Q3 2018 Mar 19, 2020	BUY	$60.81 - $73.36 $1.48 Million - $1.78 Million	24,300 Added 12.25%	222,700 $16.3 Million
Q2 2018 Mar 19, 2020	SELL	$57.57 - $63.54 $1.38 Million - $1.52 Million	-24,000 Reduced 10.79%	198,400 $12.1 Million
Q1 2018 Mar 19, 2020	SELL	$56.27 - $63.62 $2.25 Million - $2.54 Million	-40,000 Reduced 15.24%	222,400 $13.3 Million
Q4 2017 Mar 19, 2020	SELL	$53.68 - $57.47 $1.13 Million - $1.21 Million	-21,000 Reduced 7.41%	262,400 $15 Million
Q3 2017 Mar 19, 2020	SELL	$48.06 - $53.64 $672,840 - $750,960	-14,000 Reduced 4.71%	283,400 $15.1 Million
Q2 2017 Mar 19, 2020	SELL	N/A	-57,000 Reduced 16.08%	297,400 $14.5 Million
Q1 2017 Mar 19, 2020	SELL	N/A	-5,500 Reduced 1.53%	354,400 $15.7 Million
Q4 2016 Mar 19, 2020	BUY	N/A	51,000 Added 16.51%	359,900 $13.8 Million
Q3 2016 Mar 19, 2020	BUY	N/A	27,000 Added 9.58%	308,900 $13.1 Million
Q2 2016 Mar 19, 2020	BUY	N/A	43,800 Added 18.4%	281,900 $11.1 Million
Q1 2016 Mar 19, 2020	BUY	N/A	27,000 Added 12.79%	238,100 $9.96 Million
Q4 2015 Mar 19, 2020	SELL	N/A	-30,000 Reduced 12.44%	211,100 $9.48 Million
Q3 2015 Mar 19, 2020	BUY	N/A	19,000 Added 8.55%	241,100 $9.7 Million
Q2 2015 Mar 19, 2020	BUY	N/A	10,600 Added 5.01%	222,100 $10.9 Million
Q1 2015 Mar 19, 2020	BUY	N/A	32,500 Added 18.16%	211,500 $9.8 Million
Q4 2014 Mar 19, 2020	BUY	N/A	12,600 Added 7.57%	179,000 $8.06 Million
Q3 2014 Mar 19, 2020	SELL	N/A	-34,000 Reduced 16.97%	166,400 $6.92 Million
Q2 2014 Mar 19, 2020	BUY	N/A	100 Added 0.05%	200,400 $8.2 Million
Q1 2014 Mar 19, 2020	BUY	N/A	200,300	200,300 $7.71 Million

Others Institutions Holding ABT

# of Institutions

3,303

Shares Held

1.34B

Call Options Held

9.84M

Put Options Held

8.59M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $231B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bi Asset Management Fondsmaeglerselskab A, based on Form 13F filings with the SEC.

News

Stay updated on Bi Asset Management Fondsmaeglerselskab A with notifications on news.

Account

Bi Asset Management Fondsmaeglerselskab A Abbott Laboratories Transaction History